News about "API Manufacturing"

Morepen Laboratories Completes First Phase of API and CDMO Capacity Expansion Ahead of Schedule

Morepen Laboratories has increased its installed reactor capacity from 535 KL to 614 KL, strengthening manufacturing readiness for commercial CDMO scale-up and supporting its API business and future customer programs.<br />

API Manufacturing | 07/09/2026 | By News Bureau |  390

RPG Life Sciences Launches Strategic API Growth Initiative

RPG Life Sciences has launched a strategic Active Pharmaceutical Ingredient (API) initiative, with InvAscent investing in RPG Active Pharma and the unit acquiring Actis Generics.

API Manufacturing | 31/07/2026 | By News Bureau |  646

Evonik Invests USD 100 Million to Expand US Drug Manufacturing

Evonik is investing USD 100 million to upgrade its US drug substance Contract Development and Manufacturing (CDMO) facility, expanding manufacturing capacity to meet growing demand for US-based pharmaceutical outsourcing.

API Manufacturing | 10/07/2026 | By News Bureau

DST-TDB Supports Bioneemtec for Green Pharma Manufacturing Commercialisation

The Department of Science and Technology (DST) is supporting Bioneemtec India in the commercialisation of green chemistry-based pharmaceutical manufacturing technologies, aiming to strengthen indigenous API production and advance next-generation therapeutics.

API Manufacturing | 06/06/2026 | By News Bureau |  204

Anuh Pharma Gets Prequalification Nod from WHO for Anti-Malarial Bulk Drug

Anuh Pharma receives World Health Organization (WHO) prequalification for Amodiaquine Hydrochloride API, an essential anti-malarial medicine used in combination therapies for Plasmodium falciparum malaria.

API Manufacturing | 06/05/2026 | By News Bureau

Dr. Reddy's Laboratories Wins Health Canada Nod for Generic Semaglutide Injection

Dr. Reddy's Laboratories secures Health Canada approval for generic semaglutide injection, becoming the first to gain market authorisation in Canada ahead of the review timeline.

API Manufacturing | 29/04/2026 | By News Bureau |  180

Supriya Lifescience Receives US FDA EIR with VAI Status for Lote Parshuram Facility

Supriya Lifescience receives US FDA EIR with VAI classification for its Lote Parshuram facility, closing the February 2026 audit inspection cycle.

API Manufacturing | 23/04/2026 | By News Bureau |  246

Ofichem Group Unifies Global Brands Under Single Identity to Streamline Pharma Partnerships

Ofichem consolidates its global brands under one identity to deliver integrated pharmaceutical development and supply solutions.

API Manufacturing | 11/04/2026 | By News Bureau |  232

Agno Pharma Acquires Actylis's CDMO Manufacturing Asset

Agno Pharma has acquired Actylis’s CDMO manufacturing asset, the legacy Cascade Chemistry business based in Eugene, Oregon, strengthening Agno’s U. cGMP API development and manufacturing capabilities.

API Manufacturing | 19/01/2026 | By News Bureau |  260

FDA Announces New ANDA Prioritisation Pilot to Support US Generic Drug Manufacturing and Testing

More than half of pharmaceuticals distributed in the US are manufactured overseas. Further, the US is reliant on overseas sources for Active Pharmaceutical Ingredients (APIs). As of 2025, only nine percent of API manufacturers are in the US, compared to 22 percent in China and 44 percent in India.

API Manufacturing | 06/10/2025 | By Dineshwori |  198